|Event:||UBS Global Life Sciences Conference|
|Presenter:||Ron Squarer, Chief Executive Officer|
|Date:||Thursday, September 20, 2012|
|Time:||8:30 a.m. Eastern Time|
|Location:||The Grand Hyatt New York, NY|
The market isn't buying that Trump is bad for business
Such unwarranted fears have depressed the sector, which could bounce back after Nov. 8.
Following the success of Array BioPharma's (ARRY) melanoma treatment in a clinical trial announced yesterday, JPMorgan increased its price target on the stock.